Snyman Katherine, Pitt Catherine, Aturia Angelo, Aber Joyce, Gonahasa Samuel, Namuganga Jane Frances, Nankabirwa Joaniter, Arinaitwe Emmanuel, Maiteki-Sebuguzi Catherine, Katamba Henry, Opigo Jimmy, Matovu Fred, Dorsey Grant, Kamya Moses R, Ochieng Walter, Staedke Sarah G
Infectious Diseases Research Collaboration (IDRC), Plot 2C Nakasero Road, Kampala P.O. Box 7475, Uganda.
Department of Global Health & Development, London School of Hygiene & Tropical Medicine (LSHTM), Keppel Street, London WC1E 7HT, United Kingdom.
Health Policy Plan. 2025 Jan 11;40(1):52-65. doi: 10.1093/heapol/czae093.
Case management of malaria in Africa has evolved markedly over the past 20 years and updated cost estimates are needed to guide malaria control policies. We estimated the cost of malaria illness to households and the public health service and assessed the equity of these costs in Uganda. From December 2021 to May 2022, we conducted a costing exercise in eight government-run health centres covering seven sub-regions, collecting health service costs from patient observations, records review and a time-and-motion study. From November 2021 to January 2022, we gathered data on households' cost of illness from randomly selected households for 614 residents with suspected malaria. Societal costs of illness were estimated and combined with secondary data sources to estimate the total economic burden of malaria in Uganda. We used regression analyses and concentration curves to assess the equity of household costs across age, geographic location and socio-economic status. The mean societal economic cost of treating suspected malaria was $15.12 [95% confidence interval (CI): 12.83-17.14] per outpatient and $27.21 (95% CI: 20.43-33.99) per inpatient case. Households incurred 81% of outpatient and 72% of inpatient costs. Households bore nearly equal costs of illness, regardless of socio-economic status. A case of malaria cost households in the lowest quintile 26% of per capita monthly consumption, while a malaria case only cost households in the highest quintile 8%. We estimated the societal cost of malaria treatment in Uganda was $577 million (range: $302 million-1.09 billion) in 2021. The cost of malaria remains high in Uganda. Households bear the major burden of these costs. Poorer and richer households incur the same costs per case; this distribution is equal, but not equitable. These results can be applied to parameterize future economic evaluations of malaria control interventions and to evaluate the impact of malaria on Ugandan society, informing resource allocations in malaria prevention.
在过去20年里,非洲疟疾的病例管理有了显著发展,因此需要更新成本估算以指导疟疾控制政策。我们估算了疟疾疾病给家庭和公共卫生服务带来的成本,并评估了这些成本在乌干达的公平性。2021年12月至2022年5月,我们在覆盖七个次区域的八个政府运营的卫生中心开展了成本核算工作,通过患者观察、记录审查和时间动作研究收集卫生服务成本。2021年11月至2022年1月,我们从随机抽取的家庭中收集了614名疑似疟疾居民的家庭疾病成本数据。估算了疾病的社会成本,并结合二级数据源来估算乌干达疟疾的总经济负担。我们使用回归分析和集中曲线来评估家庭成本在年龄、地理位置和社会经济地位方面的公平性。治疗疑似疟疾的平均社会经济成本为门诊患者每人15.12美元[95%置信区间(CI):12.83 - 17.14],住院患者每人27.21美元(95% CI:20.43 - 33.99)。家庭承担了81%的门诊成本和72%的住院成本。无论社会经济地位如何,家庭承担的疾病成本几乎相等。一例疟疾使最贫困五分之一家庭的人均月消费支出增加26%,而在最富裕五分之一家庭中,一例疟疾仅使人均月消费支出增加8%。我们估计2021年乌干达疟疾治疗的社会成本为5.77亿美元(范围:3.02亿美元 - 10.9亿美元)。在乌干达,疟疾成本仍然很高。家庭承担了这些成本的主要负担。较贫困和较富裕家庭每例疟疾的成本相同;这种分布是平等的,但并不公平。这些结果可用于为未来疟疾控制干预措施的经济评估设定参数,并评估疟疾对乌干达社会的影响,为疟疾预防资源分配提供参考。